Three doses of vaccine are effective against Omitron

Companies, Pfizer and BioNTech announced today that three doses of this producer's vaccine against COVIED-19, they have shown that they generate neutral effects against the new version of the Coronavirus, Omitron. This conclusion was drawn after intensive tests by the company at the lab.

In the first official announcement by the vaccine manufacturer regarding the efficiency of its vaccine against Omitron, BioNTech and Pfizer announced in a joint statement that two doses of the vaccine resulted in less impact on the neutralisation of antibodies, but with the third dose of the vaccine, the increase in the neutralisation of antibodies is noted, Tch reports.

The results are preliminary until the findings are described only in a media communiqué and more data are not available yet.

The company, among other things, added that if necessary, vaccines they would have on the basis of the Omitron version could be ready by March 2022.